385
Views
16
CrossRef citations to date
0
Altmetric
Reviews

Transarterial chemoembolization and sorafenib in hepatocellular carcinoma

, , , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Omar Elshaarawy, Asmaa Gomaa, Hazem Omar, Eman Rewisha & Imam Waked. (2019) Intermediate stage hepatocellular carcinoma: a summary review. Journal of Hepatocellular Carcinoma 6, pages 105-117.
Read now
Rodolfo Sacco, Gherardo Tapete, Natalia Simonetti, Rossella Sellitri, Veronica Natali, Sara Melissari, Giuseppe Cabibbo, Lilia Biscaglia, Giampaolo Bresci & Luca Giacomelli. (2017) Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review. Journal of Hepatocellular Carcinoma 4, pages 105-110.
Read now
Yue Jin, Yanguan Lyu, Xiaolong Tang, Yanming Zhang, Jianping Chen, Donghui Zheng & Yong Liang. (2015) Lupeol enhances radiosensitivity of human hepatocellular carcinoma cell line SMMC-7721 in vitro and in vivo. International Journal of Radiation Biology 91:2, pages 202-208.
Read now
Sameh Mikhail, David Cosgrove & Amer Zeidan. (2014) Hepatocellular carcinoma: systemic therapies and future perspectives. Expert Review of Anticancer Therapy 14:10, pages 1205-1218.
Read now

Articles from other publishers (12)

Xiulan Lai & Avner Friedman. (2019) How to schedule VEGF and PD-1 inhibitors in combination cancer therapy?. BMC Systems Biology 13:1.
Crossref
Xiulan Lai & Avner Friedman. (2019) Mathematical modeling in scheduling cancer treatment with combination of VEGF inhibitor and chemotherapy drugs. Journal of Theoretical Biology 462, pages 490-498.
Crossref
Venkata K. Pokuri, Garin M. Tomaszewski, Sihem Ait-Oudhia, Adrienne Groman, Nikhil I. Khushalani, Amit A. Lugade, Yasmin Thanavala, Edward A. Ashton, Catherine Grande, Gerald J. Fetterly & Renuka Iyer. (2018) Efficacy, Safety, and Potential Biomarkers of Sunitinib and Transarterial Chemoembolization (TACE) Combination in Advanced Hepatocellular Carcinoma (HCC). American Journal of Clinical Oncology 41:4, pages 332-338.
Crossref
Peter R. Galle, Francesco Tovoli, Friedrich Foerster, Marcus A. Wörns, Alessandro Cucchetti & Luigi Bolondi. (2017) The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy. Journal of Hepatology 67:1, pages 173-183.
Crossref
Ioannis A Ziogas & Georgios Tsoulfas. (2017) Evolving role of Sorafenib in the management of hepatocellular carcinoma. World Journal of Clinical Oncology 8:3, pages 203.
Crossref
Jean-François Geschwind, Masatoshi Kudo, Jorge A. Marrero, Alan P. Venook, Xiao-Ping Chen, Jean-Pierre Bronowicki, Lucy Dagher, Junji Furuse, Laura Ladrón de Guevara, Christos Papandreou, Arun J. Sanyal, Tadatoshi Takayama, Sheng-Long Ye, Seung Kew Yoon, Keiko Nakajima, Robert Lehr, Stephanie Heldner & Riccardo Lencioni. (2016) TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON. Radiology 279:2, pages 630-640.
Crossref
Alberta Cappelli, Alessandro Cucchetti, Giuseppe Cabibbo, Cristina Mosconi, Marcello Maida, Simona Attardo, Irene Pettinari, Antonio D. Pinna & Rita Golfieri. (2015) Refining prognosis after trans‐arterial chemo‐embolization for hepatocellular carcinoma. Liver International 36:5, pages 729-736.
Crossref
Giuseppe Cabibbo, Maria Reig, Gennaro Gadaleta-Caldarola, Giovanni Galati, Giuseppe Lombardi, GianCarlo Mazza, Luca Marzi, Carlo Saitta, Jean-Charles Nault & Rodolfo Sacco. (2016) The calm before the storm: a report from the International Liver Cancer Association Congress 2015 – part 1. Future Oncology 12:3, pages 281-284.
Crossref
Rodolfo Sacco, Michela Antonucci, Irene Bargellini, Sara Marceglia, Valeria Mismas & Giuseppe Cabibbo. (2015) Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice?. Future Oncology 11:17, pages 2371-2373.
Crossref
Gennaro Gadaleta-Caldarola, Stefania Infusino, Rosa Divella, Emanuela Ferraro, Antonio Mazzocca, Ferruccio De Rose, Gianfranco Filippelli, Ines Abbate & Mario Brandi. (2015) Sorafenib: 10 years after the first pivotal trial. Future Oncology 11:13, pages 1863-1880.
Crossref
Jing-Huan Li. (2015) Oxaliplatin and 5-fluorouracil hepatic infusion with lipiodolized chemoembolization in large hepatocellular carcinoma. World Journal of Gastroenterology 21:13, pages 3970.
Crossref
Giuseppe Cabibbo, Salvatore Petta, Marcello Maida & Calogero Cammà. (2015) Sorafenib for Hepatocellular Carcinoma: From Randomized Controlled Trials to Clinical Practice. Digestive Diseases 33:5, pages 668-674.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.